# Ligand and transcriptional regulation of the nuclear receptor RORa on TH17 cell development and inflammation

> **NIH NIH R01** · UNIVERSITY OF FLORIDA · 2024 · $618,072

## Abstract

SUMMARY
The goal of our studies is to understand RORα’s role in the transcriptional regulation of TH17 cell
pathogenicity and chronic inflammation. RORα is a member of the ligand-regulated nuclear receptor
(NR) superfamily of transcription factors. Significantly less is known about RORα in the transcriptional
regulation of TH17-mediated immunity. We and others recently published RORα is required for full
TH17-cell development, particularly in mouse models of chronic inflammation. Despite this evidence,
RORα is considered functionally redundant to RORγt, the lineage defining transcription factor of TH17
cells. As ligand-regulated transcription factors, NRs evolved to respond to endogenous small
molecules, translating these signals into changes in gene expression. Synthetic small molecules can
also be utilized to understand receptor function. Our data suggests that RORα/ligand-regulation may
protect from chronic inflammation, including colitis. Given the evidence that both intra- and extra-
cellular ligands regulate NR activity in TH17 cells, defining RORα and ligand mechanisms of action is
key to understanding signaling pathways underlying homeostasis vs. pathogenesis. Therefore,
understanding these processes may be essential to understand how RORα contributes to TH17 cells
and disease. Our overarching goals are to elucidate the mechanisms that regulate RORα’s
transcriptional activity and interacting partners, thus driving functionality in TH17 cells during
inflammatory processes. Understanding RORα’s transcriptional role in TH17 cells may reveal a novel
therapeutic option for the treatment of TH17-mediated chronic inflammatory disorders. We will achieve
our goals by: 1) establishing how RORα transcriptionally promotes and maintains pathogenic TH17-
mediated inflammation and 2) using pharmacological approaches to understand how ligands affect the
transcriptional activity of RORα in TH17 cells. Collectively, our studies will uncover important
transcriptional roles for RORα in TH17 cell biology and reveal whether targeting RORα may be
advantageous for the treatment of TH17-mediated chronic inflammation.

## Key facts

- **NIH application ID:** 10824925
- **Project number:** 1R01DK136298-01A1
- **Recipient organization:** UNIVERSITY OF FLORIDA
- **Principal Investigator:** Laura A Solt
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $618,072
- **Award type:** 1
- **Project period:** 2024-04-01 → 2029-01-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10824925

## Citation

> US National Institutes of Health, RePORTER application 10824925, Ligand and transcriptional regulation of the nuclear receptor RORa on TH17 cell development and inflammation (1R01DK136298-01A1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10824925. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*